Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,904 | 27,164 | 48,786 | 108,419 | 68,299 |
| Marketable Securities | 51,535 | 90,501 | 101,617 | 57,002 | 59,652 |
| Receivables | 27,182 | 25,346 | 80,984 | 20,773 | 19,750 |
| Inventories | 3,123 | 3,260 | 2,637 | 2,625 | 2,832 |
| Other current assets | 361 | 330 | 10,155 | 1,787 | 11,495 |
| TOTAL | $151,095 | $157,609 | $256,158 | $203,003 | $174,411 |
| Non-Current Assets | |||||
| PPE Net | 3,204 | 3,432 | 3,718 | 3,963 | 4,240 |
| Intangibles | 41,447 | 42,434 | 43,421 | 44,408 | 45,395 |
| Other Non-Current Assets | 36,298 | 36,383 | 28,058 | 7,748 | 6,677 |
| TOTAL | $80,949 | $82,249 | $75,197 | $56,119 | $56,312 |
| Total Assets | $232,044 | $239,858 | $331,355 | $259,122 | $230,723 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,056 | 15,071 | 28,878 | 20,684 | 16,363 |
| Accrued Expenses | 76,771 | 74,251 | 70,281 | 46,431 | 41,517 |
| TOTAL | $88,343 | $91,661 | $101,398 | $67,115 | $57,880 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,185 | 93,434 | 152,841 | 151,886 | 121,054 |
| Other Non-Current Liabilities | 32,336 | 32,992 | 33,645 | 0 | 0 |
| TOTAL | $126,521 | $126,426 | $186,486 | $157,701 | $126,930 |
| Total Liabilities | $214,864 | $218,087 | $287,884 | $224,816 | $184,810 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,961 | 38,897 | 38,612 | 38,498 | 38,135 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -1,266,437 | -1,249,552 | -1,212,128 | -1,202,041 | -1,171,346 |
| Other shareholders' equity | 115 | 110 | 9 | -12 | -3 |
| TOTAL | $17,180 | $21,771 | $43,471 | $34,306 | $45,913 |
| Total Liabilities And Equity | $232,044 | $239,858 | $331,355 | $259,122 | $230,723 |